- Home
- NSTS vs IOBT Comparison
NSTS vs IOBT Comparison
Compare NSTS & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSTS
- IOBT
- Stock Information
- Founded
- NSTS 1921
- IOBT 2014
- Country
- NSTS United States
- IOBT Denmark
- Employees
- NSTS N/A
- IOBT N/A
- Industry
- NSTS Savings Institutions
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- NSTS Finance
- IOBT Health Care
- Exchange
- NSTS Nasdaq
- IOBT Nasdaq
- Market Cap
- NSTS 63.0M
- IOBT 50.5M
- IPO Year
- NSTS N/A
- IOBT 2021
- Fundamental
- Price
- NSTS $11.18
- IOBT $0.66
- Analyst Decision
- NSTS
- IOBT Hold
- Analyst Count
- NSTS 0
- IOBT 3
- Target Price
- NSTS N/A
- IOBT $4.00
- AVG Volume (30 Days)
- NSTS 3.7K
- IOBT 5.1M
- Earning Date
- NSTS 11-12-2025
- IOBT 11-11-2025
- Dividend Yield
- NSTS N/A
- IOBT N/A
- EPS Growth
- NSTS N/A
- IOBT N/A
- EPS
- NSTS N/A
- IOBT N/A
- Revenue
- NSTS $9,435,000.00
- IOBT N/A
- Revenue This Year
- NSTS N/A
- IOBT N/A
- Revenue Next Year
- NSTS N/A
- IOBT N/A
- P/E Ratio
- NSTS N/A
- IOBT N/A
- Revenue Growth
- NSTS 69.39
- IOBT N/A
- 52 Week Low
- NSTS $10.70
- IOBT $0.32
- 52 Week High
- NSTS $13.32
- IOBT $2.79
- Technical
- Relative Strength Index (RSI)
- NSTS 30.69
- IOBT 38.10
- Support Level
- NSTS $11.30
- IOBT $0.45
- Resistance Level
- NSTS $11.35
- IOBT $0.65
- Average True Range (ATR)
- NSTS 0.07
- IOBT 0.07
- MACD
- NSTS -0.00
- IOBT 0.04
- Stochastic Oscillator
- NSTS 2.08
- IOBT 71.90
About NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.